JAZZ
Jazz Pharmaceuticals Plc
A global biopharmaceutical company focused on rare diseases, Jazz Pharmaceuticals makes medicines for sleep disorders, epilepsy, and cancer. Its flagship products include Xywav for narcolepsy, Epidiolex for rare epilepsies, and the newer oncology drugs Ziihera and Modeyso. Founded in 2003 by Bruce Cozadd, the company took its name from the idea of jazz improvisation — innovating freely while staying grounded in a shared structure, much like musicians jamming together on stage.
CINS: G50871105ISIN: IE00B4Q5ZN47HealthcareUS1 holder
Total Value
$23.65M
Total Shares
192.0K
Net Share Change
+79.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
